1. Home
  2. HOWL vs HYPR Comparison

HOWL vs HYPR Comparison

Compare HOWL & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • HYPR
  • Stock Information
  • Founded
  • HOWL 2017
  • HYPR 2014
  • Country
  • HOWL United States
  • HYPR United States
  • Employees
  • HOWL N/A
  • HYPR N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • HYPR Medical Specialities
  • Sector
  • HOWL Health Care
  • HYPR Health Care
  • Exchange
  • HOWL Nasdaq
  • HYPR Nasdaq
  • Market Cap
  • HOWL 87.4M
  • HYPR 71.9M
  • IPO Year
  • HOWL 2021
  • HYPR N/A
  • Fundamental
  • Price
  • HOWL $1.79
  • HYPR $0.98
  • Analyst Decision
  • HOWL Strong Buy
  • HYPR Hold
  • Analyst Count
  • HOWL 2
  • HYPR 2
  • Target Price
  • HOWL $13.50
  • HYPR $1.43
  • AVG Volume (30 Days)
  • HOWL 656.6K
  • HYPR 108.9K
  • Earning Date
  • HOWL 11-07-2024
  • HYPR 11-12-2024
  • Dividend Yield
  • HOWL N/A
  • HYPR N/A
  • EPS Growth
  • HOWL N/A
  • HYPR N/A
  • EPS
  • HOWL N/A
  • HYPR N/A
  • Revenue
  • HOWL $3,386,000.00
  • HYPR $13,255,000.00
  • Revenue This Year
  • HOWL N/A
  • HYPR $31.69
  • Revenue Next Year
  • HOWL $191.98
  • HYPR $33.96
  • P/E Ratio
  • HOWL N/A
  • HYPR N/A
  • Revenue Growth
  • HOWL N/A
  • HYPR 35.67
  • 52 Week Low
  • HOWL $1.58
  • HYPR $0.76
  • 52 Week High
  • HOWL $8.19
  • HYPR $1.42
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 32.55
  • HYPR 55.67
  • Support Level
  • HOWL $1.58
  • HYPR $0.82
  • Resistance Level
  • HOWL $2.24
  • HYPR $0.98
  • Average True Range (ATR)
  • HOWL 0.16
  • HYPR 0.06
  • MACD
  • HOWL -0.09
  • HYPR 0.00
  • Stochastic Oscillator
  • HOWL 7.01
  • HYPR 86.32

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Share on Social Networks: